) homeostasis, Zn 2+ transporters, and Zn
2+
-dependent transcription factors in OA pathogenesis. Among Zn 2+ transporters, the Zn 2+ importer ZIP8 was specifically upregulated in OA cartilage of humans and mice, resulting in increased levels of intracellular Zn 2+ in chondrocytes. ZIP8-mediated Zn 2+ influx upregulated the expression of matrix-degrading enzymes (MMP3, MMP9, MMP12, MMP13, and ADAMTS5) in chondrocytes. Ectopic expression of ZIP8 in mouse cartilage tissue caused OA cartilage destruction, whereas Zip8 knockout suppressed surgically induced OA pathogenesis, with concomitant modulation of Zn 2+ influx and matrix-degrading enzymes. Furthermore, MTF1 was identified as an essential transcription factor in mediating Zn 2+ /ZIP8-induced catabolic factor expression, and genetic modulation of Mtf1 in mice altered OA pathogenesis. We propose that the zinc-ZIP8-MTF1 axis is an essential catabolic regulator of OA pathogenesis.
INTRODUCTION
Osteoarthritis (OA) is the most common of all arthropathies and is a leading cause of disability with a large socioeconomic cost. To date, however, no effective disease-modifying therapies for OA have been developed. OA is primarily characterized by cartilage destruction but also involves other pathological changes, including synovial inflammation, osteophyte formation, and subchondral bone sclerosis, in all tissues of joints (Bian et al., 2012; Loeser et al., 2012; Little and Hunter, 2013) . OA pathogenesis is caused by an imbalance between anabolic and catabolic factors. A variety of etiologic risk factors and pathophysiological processes contribute to the progressive nature of the disease. Important among potential OA-causing mechanisms are mechanical stresses, including joint instability and injury, and factors that predispose toward OA, such as aging. These factors lead to the activation of biochemical pathways in chondrocytes that result in degradation of the extracellular matrix by matrix metalloproteinases (MMPs) and aggrecanases (ADAMTSs). Among matrix-degrading enzymes, MMP3, MMP13, and ADAMTS5 are known to play crucial roles in OA cartilage destruction (Blom et al., 2007; Glasson et al., 2005; Little et al., 2009) .
Matrix-degrading enzymes require zinc (Zn 2+ ) as a structural component (Page-McCaw et al., 2007) . Indeed, Zn 2+ acts as an activator or coactivator of a variety of proteins by providing a structural scaffold, for example in the form of zinc fingers and zinc clusters (Prasad, 1995) . Zn 2+ is also found in the cytoplasm and intracellular compartments in a labile form, and changes in these Zn 2+ levels affect various cellular functions. In fact, an imbalance in Zn 2+ homeostasis is linked to abnormal embryonic development, immune dysfunction, neurological problems, and increased mortality and disease (Fukada et al., 2011) . Zn 2+ may also be overtly toxic when accumulated in excess in cells. Therefore, normal cell functioning requires tight regulation of Zn 2+ homeostasis. Zn 2+ homeostasis is primarily regulated by membrane Zn 2+ transporters of the Slc30a family (ZNT) of exporters and Slc39a family (ZIP) of importers (Cousins et al., 2006) . The ZNT family, consisting of ten members in mammals (ZNT1-ZNT10), mediates Zn 2+ efflux from cells or influx into intracellular vesicles from the cytosol. There are 14 members of the ZIP family of Zn 2+ importers in mammals (ZIP1-ZIP14) that promote Zn 2+ influx from the extracellular fluid or intracellular vesicles into the cytoplasm. Zn 2+ transporters exhibit tissuespecific functions (Liuzzi et al., 2005; Kitamura et al., 2006) , and abnormalities in the function of certain Zn 2+ transporters are associated with human diseases, such as acrodermatitis enteropathica (Kü ry et al., 2002) . Zn 2+ influx modulates a number of transcription factors in various cell types. Among them, metalregulatory transcription factor-1 (MTF1) regulates expression of a variety of target genes and thereby regulates cellular adaptation to various stress conditions, primarily exposure to heavy metals, but also hypoxia and oxidative stress (Laity and Andrews, 2007; Gü nther et al., 2012) . Zn 2+ homeostasis is additionally regulated by metal-dependent transcriptional control of storage proteins. For instance, metallothioneins (MTs), whose genes are well-known targets of MTF1, act as Zn
2+
-storage proteins and thereby regulate cellular Zn 2+ homeostasis. MTs also act as antioxidants and protect cells from oxidative stress (Laity and Andrews, 2007; Colvin et al., 2010; Gü nther et al., 2012) . There has been a growing interest in the potential role of Zn 2+ in the pathogenesis of OA. Clinical studies indicate highly elevated serum Zn 2+ levels in OA patients (Ovesen et al., 2009) and specific accumulation of Zn 2+ in the tidemark region of articular cartilage in aged populations (Roschger et al., 2013 latory genes in OA pathogenesis, we initially examined expression levels of metal ion transporters-the Slc30a family (ZNT) of exporters and Slc39a family (ZIP) of importers-in primary cultures of mouse articular chondrocytes. Among the examined transporters, ZNT9 and ZIP7 mRNAs were expressed at relatively high levels in chondrocytes, whereas many of the remaining transporters were barely detectable ( Figure 1A ). However, following treatment with interleukin (IL)1b, a proinflammatory cytokine that promotes catabolism in arthritic cartilage (Kapoor et al., 2011) , ZIP8 expression levels were markedly increased, making it the most dominantly expressed transporter among the ZNT and ZIP family members ( Figure 1A ). This led us to investigate the role of ZIP8 in OA pathogenesis. ZIP8 is known to transport Zn
, nontransferrin-bound Fe 2+ , Mn 2+ , and Cd 2+ (Dalton et al., 2005; Wang et al., 2012 , and Cd 2+ were not affected by ZIP8 overexpression alone ( Figure 1B) . However, in a certain range of each metal ion supplementation, ZIP8 effectively drove influx of these metal ions ( Figure 1B) , suggesting that the transport efficiency of each metal ion by ZIP8 is determined by the cellular microenvironmental context, with Zn 2+ evidently being the most efficiently transported by ZIP8 under our experiment conditions. Thus, we further characterized the regulation of Zn 2+ influx by ZIP8. The ZIP8-mediated increase in Zn 2+ influx was abolished by the cell-impermeable metal ion chelator, calcium-saturated EDTA (CaEDTA), or the cell-permeable chelator, N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) ( Figure 1C ). IL1b, which increased both transcript and protein levels of ZIP8 (Figure 1A, inset) , caused an influx of Zn 2+ in chondrocytes that was blocked by downregulating Zip8 with small interfering RNA (siRNA) or the metal ion chelators CaEDTA or TPEN ( Figure 1C ). Figure 1D ). Zn 2+ and ZIP8
protein and mRNA levels were markedly elevated in OA-affected human cartilage but were barely detectable in undamaged regions of arthritic cartilage ( Figure 1D ). We also used destabilization of the medial meniscus (DMM) surgery as a mouse model of OA and compared it with normal cartilage in a sham-operated joint (Glasson et al., 2007) . Similar to human OA cartilage, mouse OA cartilage showed a marked increase in Zn 2+ and ZIP8 protein and mRNA levels ( Figure 1E ). Figure 2B ). FeCl 2 treatment caused moderate expression of matrix-degrading enzymes. However, chelation of ferric or ferrous with Zn/DFO or 2,2-bipyridyl, respectively, did not affect Ad-Zip8-induced expression of matrix-degrading enzymes ( Figure 2C ), consistent with the fact that ZIP8 did not cause Fe 2+ influx without exogenous FeCl 2 supplementation.
ZIP8-Mediated
Furthermore, preincubation of TPEN with ZnCl 2 effectively abolished the inhibitory effects of TPEN on the ZIP8-mediated expression of matrix-degrading enzymes, whereas FeCl 2 , CdCl 2 , and MnCl 2 showed no significant effects on TPEN inhibition of the ZIP8-mediated upregulation of matrix-degrading enzymes ( Figure 2D ). These results collectively suggest that Zn 2+ , among the metal ions transported by ZIP8, plays a major role in ZIP8 regulation of the expression of matrix-degrading enzymes. Among the ZIP8-regulated matrix-degrading enzymes, MMP3, MMP13, and ADAMTS5 are crucial effectors of OA cartilage destruction (Blom et directly examined by intra-articular (IA) injection of Ad-Zip8 into mouse knee joints. We have previously shown that the adenoviral system effectively delivers genes into mouse joint tissues (Yang et al., 2010; Ryu et al., 2011 Ryu et al., , 2012 Oh et al., 2012) and further confirmed gene delivery via this system by injecting Ad-eGFP ( Figure S1B 3C ). IA injection of Ad-Zip8 also caused synovitis ( Figure S1C ). Consistent with this, overexpression of ZIP8 in primary cultured mouse fibroblast-like synoviocytes caused upregulation of various catabolic factors, including matrix-degrading enzymes, cytokines, and chemokines ( Figure S1D ). Additionally, Ad-Zip8-induced MMP expression, cartilage destruction, and synovitis were significantly blocked by coinjection of TPEN (Figures 3A, 3B, and S1C). Other OA manifestations, such as osteophyte development and subchondral bone sclerosis, were not observed at 3 weeks after Ad-Zip8 injection. However, 8 weeks after IA injection, joint tissues exhibited osteophyte development and subchondral bone sclerosis with more severe cartilage destruction ( Figure S1E ). Collectively, these results demonstrate that ZIP8-mediated Zn 2+ influx acts as a catabolic regulator of OA pathogenesis. The in vivo role of ZIP8-mediated Zn 2+ influx in OA pathogenesis was further validated using chondrocyte-specific Zip8-overexpressing transgenic (TG) mice (Col2a1-Zip8), in which Zip8 expression is driven by the promoter and enhancer region of mouse Col2a1 (Yang et al., 2010; Oh et al., 2012) . Col2a1-Zip8 TG mice expressed markedly enhanced levels of ZIP8 in cartilage and meniscus, but not in the synovium or ligaments, of joint tissues ( Figures 3D and S2A ). Zip8 TG mice also showed increased levels of Zn 2+ , MMP3, and MMP13 in cartilage tissue ( Figure 3D ). Consistent with this, aged (12-month-old) Zip8 TG mice exhibited spontaneous cartilage destruction ( Figure 3E ), with Osteoarthritis Research Society International (OARSI) grades ranging from 1 to 6 ( Figure S2D ) and subchondral bone sclerosis ( Figure 3F ) compared with age-matched wild-type (WT) mice; synovitis was not observed in Zip8 TG mice (Figure 3G) . Additionally, DMM surgery in young (10-12 weeks old) Zip8 TG mice showed significantly enhanced OA cartilage destruction ( Figure 3H ) and subchondral bone sclerosis, whereas synovitis and osteophyte development were not affected ( Figures S2E and S2F ). These features of Zip8 TG mice clearly support the notion that ZIP overexpression in cartilage tissue is sufficient to cause OA pathogenesis.
Zip8 Knockout in Mice Inhibits Experimental OA Pathogenesis We next confirmed the catabolic role of ZIP8 in OA pathogenesis using Zip8-knockout (KO) mice. Because homozygous deletion of Zip8 in mice (Zip8 ing a transcription factor array kit. Among the 37 transcription factors examined, MTF1, NRF1 and NRF2, NF-kB, SP1, p53, C/EBP, and AP1 showed more than a 3-fold increase in transcriptional activity following Ad-Zip8 infection ( Figure S3A ). Pharmacological inhibition of p53, AP1, or NF-kB or siRNAmediated knockdown of Nrf or Cebpb had no significant effect (A and B) mRNA levels were quantified by qRT-PCR in chondrocytes infected with Ad-C or Ad-Zip8 with or without CaEDTA or TPEN (n R 6) (A) or treated with 100 mM of ZnCl 2 , FeCl 2 , or MnCl 2 and 1 mM of CdCl 2 (n = 6) (B).
(C) The indicated mRNAs were detected in chondrocytes infected with Ad-C or Ad-Zip8 in the absence or presence of the indicated concentrations of iron chelators, Zn/DFO, 2,2-bipyridyl, or Mn 2+ chelator para-aminosalicylic acid (PAS) (n = 4).
(D) mRNA levels of matrix-degrading enzymes in chondrocytes infected with Ad-C or Ad-Zip8 with or without TPEN (1 mM) or TPEN preincubated with 1 mM of the indicated metal ion (n = 5).
(E) qRT-PCR analysis (n R 6) of mRNA levels of ZIP8 and matrix-degrading enzymes in chondrocytes treated with IL1b, with or without control or Zip8 siRNA, TPEN, or CaEDTA.
(F) Expression of matrix-degrading enzymes, determined by western blotting.
Values are presented as means ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001). See also Table S1 .
on Ad-Zip8-induced upregulation of matrix-degrading enzymes ( Figures S3C and S3D ). However, knockdown of Mtf1 with siRNA or inhibition of SP1 with mithramycin-A significantly attenuated ZIP8-induced upregulation of matrix-degrading enzymes (Figures S3E and S3G) . Based on these observations and the fact that MTF1 is a master transcriptional regulator of cellular adaptation under conditions of exposure to heavy metals (Laity and Andrews, 2007; Gü nther et al., 2012) , we selected MTF1 for functional characterization in ZIP8-induced OA pathogenesis. Ad-Zip8 infection promoted the nuclear localization of MTF1 ( Figure 5A ) and significantly increased its transcriptional activity ( Figure 5B ) without modulating its expression ( Figure S4A ). Notably, adenoviruses expressing mouse Mtf1 (Ad-Mtf1) infection significantly upregulated expression of matrix-degrading enzymes (MMP3, MMP9, MMP12, MMP13, and ADAMTS5), an effect that was abolished by CaEDTA or TPEN ( Figures 5C and  5D ). Additionally, ZIP8 or Zn 2+ -induced upregulation of matrixdegrading enzymes was significantly reduced by siRNA-mediated knockdown of Mtf1 ( Figures S3E and S3F ). Among the ZIP8-regulated metal ions, Zn 2+ was the most effective in regulating nuclear localization and transcriptional activation of MTF1 and Fe 2+ and Mn 2+ had no effect on MTF1 activity ( Figures   S4B and S4C ). Although Cd 2+ caused a moderate activation of MTF1 ( Figure S4C ), it had no significant effect on the expression of matrix-degrading enzymes, except for a modest induction of MMP12 expression ( Figure 2B ). This suggests that, unlike the mRNA levels of ZIP8 (C) and matrix-degrading enzymes (D) were determined by qRT-PCR (n R 4). (E and F) Synovitis (E) and subchondral bone sclerosis/osteophyte formation (F) in sham-and DMM-operated Zip8 fl/fl and Zip8-CKO mice (n = 10).
Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.01, **p < 0.005, ***p < 0.001). See also Figure S4D ). These results collectively suggest that ZIP8-mediated Zn 2+ influx promotes MTF1 transcriptional activity, which in turn upregulates expression of matrix-degrading enzymes in chondrocytes.
MTF1 Mediates ZIP8-Induced OA Pathogenesis in Mice
We next examined the in vivo role of MTF1 in OA pathogenesis. In human cartilage tissues, both MTF1 mRNA and protein were detected at high levels in OA-affected cartilage tissue compared with undamaged regions of arthritic cartilage ( Figure 6A ). The in vivo function of MTF1 was evaluated by IA injection of Ad-Mtf1 in mice, which caused MTF1 overexpression in the joint tissues ( Figures 6B and S5A ). Expression levels of MTF1, MMP3, and MMP13 in the chondrocytes of cartilage tissue were markedly enhanced at 3 weeks after Ad-Mtf1 injection ( Figure 6B ) with concomitant cartilage destruction ( Figure 6C ). IA injection of Ad-Mtf1 also caused synovial inflammation ( Figure S5B ), and overexpression of MTF1 in fibroblast-like synoviocytes caused upregulation of various catabolic factors, including matrix-degrading enzymes, cytokines, and chemokines ( Figure S5C ). Similar to the effects of Ad-Zip8 injection, Ad-Mtf1 injection in mice caused osteophyte formation and subchondral bone sclerosis at 8 weeks after IA injection, with more severe cartilage destruction ( Figure S5D ). We also confirmed MTF1 function in OA pathogenesis using Mtf1-KO mice. Chondrocyte-specific CKO mice ( Table S1 .
( Figure 6E ). DMM-operated Mtf1-CKO mice also exhibited inhibition of subchondral bone sclerosis without significant effects on synovitis or osteophyte formation ( Figure 6F Figure S6A ). In contrast, local deletion of Zip8 by Ad-Cre injection in Zip8 fl/fl mice did not affect Ad-Mtf1-induced cartilage destruction or synovitis ( Figure S6B ). This clearly supports the notion that MTF1 is a downstream mediator of ZIP8 in OA pathogenesis and ZIP8-activated MTF1 acts as a catabolic regulator of OA Figure S7A ). Consistent with this, intraperitoneal administration of ZnCl 2 augmented DMM-induced cartilage destruction ( Figure S7B ). Taken together, these observations indicate that Zn 2+ levels are positively correlated with OA pathogenesis, consistent with our findings that ZIP8-mediated Zn 2+ influx and MTF1 activation favor OA development.
Knockout of MT Genes Enhances OA Cartilage Destruction in Mice
MTs, which are well-known targets of MTF1, regulate Zn 2+ homeostasis by virtue of their function as Zn 2+ -storage proteins, and they protect cells from oxidative stress by acting as antioxidants (Laity and Andrews, 2007; Colvin et al., 2010; Fukada et al., 2011 Figure 7C ) and subchondral bone sclerosis without significant effects on synovitis and osteophyte formation (Figures 7D and 7E) . These results collectively suggest that MTF1 activation caused by ZIP8-mediated Zn 2+ influx activates a catabolic cascade by upregulating matrix-degrading enzymes, whereas upregulation of MT1 and MT2 proteins by MTF1 forms a negative feedback loop that alleviates zinc-cascade-induced OA pathogenesis. (Prasad, 1995) . Indeed, there are more than 100 Zn
DISCUSSION

2+
-dependent enzymes and more than 2,000 Zn
-dependent transcription factors in mammals (Andreini et al., 2006) . The matrix-degrading enzymes involved in OA cartilage destruction also require Zn 2+ as a structural component (Page-McCaw et al., 2007) . In this study, we revealed that Zn 2+ influx is involved in the transcriptional upregulation of MMP3, MMP9, MMP12, MMP13, and ADAMTS5 in articular chondrocytes. Among these, MMP3, MMP13, and ADAMTS5 are crucial effectors of OA cartilage destruction (Blom et al., 2007; Glasson et al., 2005; Little et al., 2009 (Laity and Andrews, 2007; Gü nther et al., 2012) . In articular chondrocytes, ZIP8-mediated Zn 2+ influx activated numerous transcription factors, including MTF1, NRF1/NRF2, NF-kB, SP1, p53, C/EBP, and AP1. Among these activated transcription factors, MTF1 and SP1 were associated with the ZIP8-mediated expression of matrix-degrading enzymes. MTF1 is involved in cellular adaptation to various stress conditions, primarily exposure to heavy metals such as Zn 2+ but also hypoxia and oxidative stress. This function of MTF1 is associated with its ability to regulate expression of a variety of target genes (Laity and Andrews, 2007; Gü nther et al., 2012) . We found that MTF1 activation in chondrocytes is sufficient to induce expression of the matrix-degrading enzymes, MMP3, MMP9, MMP12, MMP13, and ADAMTS5. These enzymes were also upregulated by ZIP8-mediated Zn 2+ influx, suggesting that ZIP8 acts through MTF1 to induce expression of matrix-degrading enzymes. Indeed, the OA pathogenesis caused by Ad-Zip8 injection was significantly inhibited in Mtf1-deficient mice, whereas Ad-Mtf1-caused OA pathogenesis was not affected in Zip8-deficient mice. This clearly suggests that MTF1 is a downstream mediator of ZIP8 in OA pathogenesis. However, siRNAmediated knockdown of Mtf1 or genetic deletion of Mtf1 in mice did not completely block ZIP8-mediated catabolic factor expression and OA pathogenesis, respectively. This suggests that other factors in addition to MTF1 are likely involved in ZIP8-mediated expression of matrix-degrading enzymes and, hence, OA pathogenesis. It is well appreciated that regulatory pathways of gene expression are very complex, with multiple factors in each regulatory step. Indeed, our current results revealed that inhibition of SP1, which is activated by ZIP8-mediated Zn 2+ influx, blocked the upregulation of matrix-degrading enzymes induced by Ad-Zip8 infection, suggesting that SP1 is also associated with ZIP8-induced OA pathogenesis. Nevertheless, IA injection of Ad-Mtf1 caused OA pathogenesis, whereas Mtf1-KO mice exhibited suppressed DMM-induced OA pathogenesis. This clearly supports the notion that MTF1 functions as an essential downstream mediator of ZIP8-induced OA pathogenesis by virtue of its role in upregulating matrix-degrading enzymes. OA is primarily characterized by cartilage destruction. However, OA is considered to be a whole-joint disease, with pathological changes, including cartilage destruction, synovial inflammation, osteophyte development, and subchondral bone double-KO mice (n = 13). Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.005, **p < 0.001). See also Table S1 .
sclerosis occurring in all tissues of the joint (Bian et al., 2012; Loeser et al., 2012; Little and Hunter, 2013) . Therefore, biochemical and biomechanical crosstalk among different joint tissue compartments likely plays an important role in the onset and progression of OA. In this context, synovial inflammation in the joint tissue might contribute to OA pathogenesis by promoting the production of various OA-regulating factors (i.e., cytokines and chemokines) by synovial cells . Indeed, we found that IA injection of Ad-Zip8 or Ad-Mtf1 promoted the expression of various matrix-degrading enzymes, cytokines, and chemokines in fibroblast-like synoviocytes and caused synovial inflammation, effects that were blocked by coinjection of the metal chelator TPEN. Although a contribution of this synovitis to cartilage destruction cannot be ruled out, the spontaneous cartilage destruction observed upon aging and the enhanced cartilage destruction induced by DMM surgery in Col2a1-Zip8 TG mice, without apparent synovial inflammation, suggests that activation of the zinc cascade in chondrocytes is sufficient to cause OA pathogenesis. In addition to cartilage destruction and synovitis, IA injection of Ad-Zip8 or Ad-Mtf1 caused subchondral bone sclerosis and osteophyte formation. Consistent with this, genetic deletion of Zip8 or Mtf1 in mice effectively inhibited cartilage destruction and subchondral bone sclerosis, whereas overexpression of Zip8 in Col2a1-Zip8 TG mice enhanced these manifestations. Therefore, changes in cartilage destruction and subchondral bone sclerosis caused by genetic modulation of Zip8 and Mtf1 are highly correlated. However, whereas these correlations have been noted in various OA models, it is still unclear how these two compartments interact each other and which of these two events is more critically associated with the initiation of OA. Given the nature of Col2a1 promoter-driven expression in the TG and CKO mice used in this study, it is likely that subchondral bone sclerosis is a consequence of the altered functions of chondrocytes in articular cartilage. For example, accelerated cartilage damage in Zip8 TG mice would augment the mechanical stress imposed on the underlying bone, whereas reduced cartilage degeneration in Zip8-or Mtf1-CKO mice would alleviate the loading caused by joint instability in the subchondral bone, thereby ameliorating subchondral bone sclerosis. In contrast, genetic modulation of Zip8 and Mtf1 in mice did not affect osteophyte formation, indicating that catabolic pathways regulated by ZIP8 and MTF1 are not associated with this process. This notion is further supported by reports that deletion of either Mmp13 or Adamts5, which are the key effectors of OA catabolism, does not prevent osteophyte development in a surgically induced OA model (Botter et al., 2009; Little et al., 2009 ). Metal-sensing MTF1 also regulates Zn 2+ homeostasis by modulating selective Zn 2+ transporters and MTs (Laity and Andrews, 2007; Gü nther et al., 2012) . MTs, which are small cysteine-rich proteins, bind to Zn 2+ and thereby regulate cellular Zn 2+ concentration and intracellular distribution (Blindauer and Leszczyszyn, 2010) . In addition to this Zn 2+ -storage function,
MTs also act as antioxidants. This antioxidant potential, as well as the ability of MTs to suppress inflammatory cytokines, including IL1b, protects against allergic inflammation (Penkowa et al., 2001 ;Mt2 À/À double-KO mice. All mice used in this study showed normal skeletal development (data not shown). Animals were maintained under pathogen-free conditions. All experiments were approved by the Gwangju Institute of Science and Technology Animal Care and Use Committee. Experimental OA was induced by DMM surgery using 10-to 12-week-old male mice; sham-operated mice were used as controls (Glasson et al., 2007) . Knee joints were processed for histological analysis 8 weeks after surgery. However, in studies involving Col2a1-Zip8 TG mice and Mt1
;Mt2 À/À double-KO mice, the duration after surgery was adjusted to 6 weeks. Experimental OA was also induced by IA injection (once weekly for 3 weeks) of Ad-Zip8 or Ad-Mtf1 (1 3 10 9 plaque-forming units in a total volume of 10 ml) into 10-to 12-week-old male mice; IA injection of empty adenovirus (Ad-C) was used as a control. Mice were sacrificed 3 or 8 weeks after the first IA injection for histological and biochemical analyses. Where indicated, the mice were coinjected (IA) with 0.1 mg/kg body weight of TPEN.
Histology and Immunohistochemistry
Human OA cartilage was frozen, sectioned at 10 mm thickness, and fixed in paraformaldehyde. Sulfate proteoglycan was detected with Alcian blue staining. Human ZIP8 was detected by immunostaining. Cartilage destruction in mice was examined using safranin-O staining. Briefly, knee joints were fixed in 4% paraformaldehyde, decalcified in 0.5 M EDTA, and embedded in paraffin. The paraffin blocks were sectioned at a thickness of 5 mm. Serial sections were obtained from the entire joint at 40 mm intervals. Sections were deparaffinized in xylene, hydrated with graded ethanol, and stained with safranin-O. Cartilage destruction was scored by two blinded observers using the OARSI grading system (Glasson et al., 2010) . Synovitis was determined by safranin-O and hematoxylin staining, and synovial inflammation (grade 0-3) was scored as described previously (Yang et al., 2010) . Osteophyte development was identified by safranin-O staining, and osteophyte maturity was quantified as described previously (Oh et al., 2012) . Subchondral bone sclerosis was determined by measuring the thickness of the subchondral bone plate (Zhen et al., 2013) . Antibodies used for immunostaining of cartilage sections are described in detail in Extended Experimental Procedures.
Primary Culture of Articular Chondrocytes
Chondrocytes were isolated from femoral condyles and tibial plateaus of mice, as described previously (Yang et al., 2010; Ryu et al., 2012; Oh et al., 2012) . Chondrocytes were maintained as a monolayer in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics, and cells at culture day 2 were treated as indicated in each experiment.
Adenoviruses and Infection of Chondrocytes
Adenoviruses expressing mouse Zip8 (Ad-Zip8) and Ad-Mtf1 were purchased from Vector Biolabs. Mouse articular chondrocytes were cultured for 2 days, infected with Ad-C, Ad-Zip8, or Ad-Mtf1 for 2 hr at the indicated multiplicity of infection (MOI), and cultured for 24 hr, followed by further analyses. , and Cd 2+ were measured by using FluoZin-3 AM, ferrozine assay, cellular Fura-2 manganese extraction assay, and Leadmium Green AM, respectively. Detailed procedures are described in Extended Experimental Procedures.
Transport of Metal Ions
MTF1 Activity Reporter Gene Assay and Immunostaining
The MTF1 reporter gene assay kit was obtained from SABiosciences. Chondrocytes were transfected for 6 hr with a metal response element reporter construct and a constitutive Renilla luciferase construct using Lipofectamine 2000 (Invitrogen). Transfected cells were infected with Ad-Mtf1 or Ad-Zip8 for 2 hr or treated with metal ions. Cells were harvested 24 hr after treatment, and firefly luciferase and Renilla luciferase activities were measured using a Dual Luciferase Assay System (Promega). For immunostaining, cells were fixed in ice-cold 4% paraformaldehyde (pH 7.4), permeabilized with 0.2% Triton X-100 in PBS, and serially blocked with Image-iT FX Signal Enhancer (Invitrogen) and PBS containing 10% goat serum/0.1% bovine serum albumin. MTF1 was detected by immunofluorescence microscopy. Images were acquired using a fluorescence microscope, and at least 200 cells were examined in multiple fields per condition to quantify the percentage of nuclear MTF1-positive cells.
RT-PCR, qRT-PCR, and siRNA Total RNA was extracted from primary cultured chondrocytes using the TRI reagent (Molecular Research Center). For the isolation of RNA from knee joints, cartilage tissues were scraped with a blade to remove cartilage and RNA was isolated using the TRI reagent and Purelink RNA mini kit (Ambion). The RNA was reverse transcribed, and the resulting cDNA was amplified by PCR. PCR primers and experimental conditions are summarized in Table S1 . Transcript levels were quantified by quantitative RT-PCR (qRT-PCR). siRNAs targeting Zip8 and Mtf1 were obtained from Dharmacon and transfected using Lipofectamine 2000. Nontargeting (scrambled) siRNA was used as a negative control. Chondrocytes were transfected by incubating for 6 hr with siRNA and Lipofectamine 2000, as described by the manufacturer, and infected with adenoviruses as described above.
Western Blotting
Total cell lysates were prepared in lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris, 5 mM NaF) and used to detect cellular proteins (ZIP8, MTF1, and ERK). Secreted proteins (MMP3, MMP13, and ADAMTS5) were detected after trichloroacetic acid (TCA) precipitation from 900 ml of serum-free conditioned medium. All lysis buffers contained a cocktail of protease inhibitors and phosphatase inhibitors (Roche). Source of antibodies are described in detail in Extended Experimental Procedures.
Statistical Analysis
Data quantified based on an ordinal grading system, such as OARSI grade, were analyzed using nonparametric statistical methods. For qRT-PCR data expressed as relative fold changes, Student's t test and ANOVA with post hoc tests were used for pairwise comparisons and multicomparisons, respectively, after confirming a normal distribution using the Shapiro-Wilk test. Significance was accepted at the 0.05 level of probability (p < 0.05). 
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